EGFL7 and neoplasm: miR-126 downregulates epidermal growth factor-like domain multiple 7 (EGFL7), a tumor-suppressor in OSCC, thereby regulating vascular endothelial growth factor (VEGF), Notch, and Wnt signaling pathways.